Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the ...

We recently published a list of Jim Cramer Tells Viewers To Not Trust Billionaires & Discusses These 11 Stocks.

Two new Canadian studies are the largest to date looking at death rates and psychosis associated with cannabis use disorder.

Bristol Myers Squibb clocked $10 million in sales for new schizophrenia drug Cobenfy in the fourth quarter of 2024, with the ...

Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive ...

Why is Secretary of State Marco Rubio allowing a crank who spews CCP propaganda to serve as a senior diplomat?

Potent cannabis linked to surging schizophrenia cases - New schizophrenia cases linked to cannabis use disorder more than doubled in Ontario after legalisation of drug ...

Austin's attorney requested the delay after the autopsy report "revealed the alleged victim’s medical history included ...

Schizophrenia cases associated with problematic weed use have skyrocketed in the wake of Canada's legalization of marijuana, ...

Learn more about whether Alkermes plc or Veracyte, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Dr Sanjoy Kumar said he would be writing to the Health Secretary demanding doctors are held responsible over Valdo Calocane.

In people with treatment-resistant depression, investigational inhalable mebufotenin yielded a 15.5-point placebo-adjusted ...